FDA warnings that dietary supplements containing cannabis extract cannabidiol are adulterated because the substance is being studied as an investigational new drug leave open a door for firms to convince the agency that the ingredient's use in supplements pre-dates the INDs.
The warning letters published Feb. 10 to six firms making disease claims for their products are the agency's first since its
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?